Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic

Wensi Zhao; Hu Qiu; Yi Gong; Chen Han; Shasha Ruan; Chenyu Wang; Jiamei Chen; Shaobo Ke; Wei Shi; Jing Wang; Qiuni Xu; Yan Li; Yuxia Shi; Qian Chen; Yongshun Chen

Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic

Am J Cancer Res. 2020 Aug 1;10(8):2282-2292. eCollection 2020.

Authors

Wensi Zhao¹, Hu Qiu¹, Yi Gong¹, Chen Han¹, Shasha Ruan¹, Chenyu Wang¹, Jiamei Chen¹, Shaobo Ke¹, Wei Shi¹, Jing Wang¹, Qiuni Xu¹, Yan Li¹, Yuxia Shi¹, Qian Chen¹, Yongshun Chen¹

Affiliation

¹ Department of Clinical Oncology, Renmin Hospital of Wuhan University Wuhan 430060, China.

PMID: 32905504
PMCID: PMC7471365

Abstract

The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures.

Keywords: COVID-19; cancer patients; clinical management.

Publication types

Review